Allison Tong and Jonathan C. Craig

Size: px
Start display at page:

Download "Allison Tong and Jonathan C. Craig"

Transcription

1 Official Journal of the VOL 63, NO 1, JANUARY 2014 xiv xv xviii Announcement This Month in AJKD Quiz Page: Cachexia, Urinary Tract Infection, Nephromegaly, and Kidney Failure Andrew Storm, Bhavna Bhasin, Deepa Rangachari, and C. John Sperati EDITORIALS IN THE LITERATURE 1 Horses for Courses: Promoting Transparent Reporting of Qualitative Research in AJKD Allison Tong and Jonathan C. Craig 4 Do We Need to Check Our Genes for a Correct Estimate of GFR? Carsten A. Böger Related Article, p Kidney Disease and Death From Cancer Colm Magee Related Article, p Glycemic Control and Mortality in Diabetic Patients Undergoing Hemodialysis: Much More to Learn Rudolf W. Bilous Related Article, p Evidence of Comparative Effectiveness Without Evidence of Effectiveness: The Case of Phosphate Binders in CKD Katrin Uhlig Cover Illustration: See January e-supplement Continued

2 Contents, Continued ORIGINAL INVESTIGATIONS Pathogenesis and Treatment of Kidney Disease 16 Association of a Cystatin C Gene Variant With Cystatin C Levels, CKD, and Risk of Incident Cardiovascular Disease and Mortality Conall M. O Seaghdha, Adrienne Tin, Qiong Yang, Ronit Katz, YongMei Liu, Tamara Harris, Brad Astor, Josef Coresh, Caroline S. Fox, W.H. Linda Kao, and Michael G. Shlipak Editorial, p Reduced Estimated GFR and Cancer Mortality Samuel Iff, Jonathan C. Craig, Robin Turner, Jeremy R. Chapman, Jie J. Wang, Paul Mitchell, and Germaine Wong Editorial, p Estimated GFR and Risk of Hip Fracture in Older Men: Comparison of Associations Using Cystatin C and Creatinine Kristine E. Ensrud, Neeta Parimi, Howard A. Fink, Areef Ishani, Brent C. Taylor, Michael Steffes, Jane A. Cauley, Cora E. Lewis, and Eric S. Orwoll, on behalf of the Osteoporotic Fractures in Men (MrOS) Study Group 40 Insights From the Use in Clinical Practice of Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome Affecting the Native Kidneys: An Analysis of 19 Cases Fadi Fakhouri, Yahsou Delmas, François Provot, Christelle Barbet, Alexandre Karras, Raifah Makdassi, Cécile Courivaud, Khair Rifard, Aude Servais, Catherine Allard, Virginie Besson, Maud Cousin, Valérie Châtelet, Jean-Michel Goujon, Jean-Philippe Coindre, Guillaume Laurent, Chantal Loirat, and Véronique Frémeaux-Bacchi 49 Estimation of GFR in South Asians: A Study From the General Population in Pakistan Saleem Jessani, Andrew S. Levey, Rasool Bux, Lesley A. Inker, Muhammad Islam, Nish Chaturvedi, Christophe Mariat, Christopher H. Schmid, and Tazeen H. Jafar 59 Comparison of Associations of Outcomes After Stroke With Estimated GFR Using Chinese Modifications of the MDRD Study and CKD-EPI Creatinine Equations: Results From the China National Stroke Registry Xianwei Wang, Yang Luo, Yilong Wang, Chunxue Wang, Xingquan Zhao, David Wang, Liping Liu, Gaifen Liu, and Yongjun Wang, on behalf of the China National Stroke Registry Investigators

3 68 Association of Fluid Overload With Kidney Disease Progression in Advanced CKD: A Prospective Cohort Study Yi-Chun Tsai, Jer-Chia Tsai, Szu-Chia Chen, Yi-Wen Chiu, Shang-Jyh Hwang, Chi-Chih Hung, Tzu-Hui Chen, Mei-Chuan Kuo, and Hung-Chun Chen Hypertension and Acid-Base/Electrolyte Disorders Dialysis CASE REPORTS 76 Prehypertension and Incidence of ESRD: A Systematic Review and Meta-analysis Yuli Huang, Xiaoyan Cai, Jianyu Zhang, Weiyi Mai, Sheng Wang, Yunzhao Hu, Hao Ren, and Dingli Xu 84 Glycated Hemoglobin and Risk of Death in Diabetic Patients Treated With Hemodialysis: A Meta-analysis Christopher J. Hill, Alexander P. Maxwell, Christopher R. Cardwell, Barry I. Freedman, Marcello Tonelli, Masanori Emoto, Masaaki Inaba, Yasuaki Hayashino, Shunichi Fukuhara, Tomonari Okada, Christiane Drechsler, Christoph Wanner, Anna Casula, Amanda I. Adler, Claudia Lamina, Florian Kronenberg, Elani Streja, Kamyar Kalantar-Zadeh, and Damian G. Fogarty Editorial, p Timing of Arteriovenous Fistula Creation in Patients With CKD: A Decision Analysis Steven M. Shechter, M. Reza Skandari, and Nadia Zalunardo 104 Objectives and Design of the Hemodialysis Fistula Maturation Study Laura M. Dember, Peter B. Imrey, Gerald J. Beck, Alfred K. Cheung, Jonathan Himmelfarb, Thomas S. Huber, John W. Kusek, Prabir Roy-Chaudhury, Miguel A. Vazquez, Charles E. Alpers, Michelle L. Robbin, Joseph A. Vita, Tom Greene, Jennifer J. Gassman, and Harold I. Feldman, on behalf of the Hemodialysis Fistula Maturation Study Group 113 Acute Oxalate Nephropathy Associated With Clostridium difficile Colitis Abraham Cohen-Bucay, Pranav Garimella, Chukwudi Ezeokonkwo, Vanesa Bijol, James A. Strom, and Bertrand L. Jaber Continued

4 Contents, Continued 119 Adult-Onset Eculizumab-Resistant Hemolytic Uremic Syndrome Associated With Cobalamin C Deficiency Emilie Cornec-Le Gall, Yahsou Delmas, Loïc De Parscau, Laurent Doucet, Hélène Ogier, Jean-François Benoist, Véronique Fremeaux-Bacchi, and Yannick Le Meur NARRATIVE REVIEW 124 The Roads Less Traveled? Diverging Research and Clinical Priorities for Dialysis Patients and Those With Less Severe CKD Marcello Tonelli WORLD KIDNEY FORUM 133 Financial Incentives to Increase Canadian Organ Donation: Quick Fix or Fallacy? John S. Gill, Scott Klarenbach, Lianne Barnieh, Timothy Caulfield, Greg Knoll, Adeera Levin, and Edward H. Cole ACID-BASE AND ELECTROLYTE TEACHING CASE 141 Approach to Diagnosis and Treatment of Hypercalcemia in a Patient With Malignancy Patrick Reagan, Antonello Pani, and Mitchell H. Rosner KIDNEY BIOPSY TEACHING CASE 148 Triamterene Crystalline Nephropathy Samih H. Nasr, Dawn S. Milliner, Thomas D. Wooldridge, and Sanjeev Sethi CORE CURRICULUM IN NEPHROLOGY CORRESPONDENCE Letters to the Editor 153 Hemodialysis: Core Curriculum 2014 Thomas A. Golper, Rachel Fissell, William H. Fissell, P. Matthew Hartle, M. Lee Sanders, and Gerald Schulman 164 The Change History of the INDEPENDENT Study in the ClinicalTrials.gov Database Yoshitsugu Obi and Takayuki Hamano 164 In Reply to The Change History of the INDEPENDENT Study in the ClinicalTrials.gov Database Biagio Di Iorio

5 165 Buttonhole Cannulation Technique as the Cannulation Method of Choice Jennifer M. MacRae, Sofia B. Ahmed, and Brenda R. Hemmelgarn 165 Urate Oxidase Should Remain Mandatory in Patients at High Risk of Tumor Lysis Syndrome Michael Darmon, Aurelie Bourmaud, and François Vincent Research Letters NOTICE 166 Beneficial Effect of Eculizumab on Thrombotic Microangiopathies: Another Point of View Se Jin Park and Jae Il Shin 167 In Reply to Beneficial Effect of Eculizumab on Thrombotic Microangiopathies: Another Point of View Jan Schmidtko and Sven Peine 167 SCr and SCysC Concentrations Before and After Traumatic Amputation in Male Soldiers: A Case-Control Study John S. Thurlow, Kevin C. Abbott, Alison Linberg, Dustin Little, Joshua Fenderson, and Stephen W. Olson 170 Pharmacokinetics and Pharmacodynamics of Imipenem and Meropenem in Critically Ill Patients Treated With Continuous Venovenous Hemodialysis David Afshartous, Seth R. Bauer, Michael J. Connor, Olufemi A. Aduroja, Milen Amde, Charbel Salem, Joseph J. Groszek, and William H. Fissell 171 Opioid Use in the US Hemodialysis Population Anne M. Butler, Abhijit V. Kshirsagar, and M. Alan Brookhart After page 173 National Kidney Foundation 2014 Spring Clinical Meetings Preliminary Program for Physicians -

List of authors and affiliations :

List of authors and affiliations : List of authors and affiliations : Fadi Fakhouri 1, Marc Fila 2, François Provot 3, Yahsou Delmas 2, Christelle Barbet 5, Valérie Châtelet 6, Cédric afat 7, Mathilde Cailliez 8, Julien Hogan 9, Aude Servais

More information

Concept and General Objectives of the Conference: Prognosis Matters. Andrew S. Levey, MD Tufts Medical Center Boston, MA

Concept and General Objectives of the Conference: Prognosis Matters. Andrew S. Levey, MD Tufts Medical Center Boston, MA Concept and General Objectives of the Conference: Prognosis Matters Andrew S. Levey, MD Tufts Medical Center Boston, MA General Objectives Topics to discuss What are the key outcomes of CKD? What progress

More information

Two Concurrent DAC Trials. Dialysis Access Consortium (DAC) Two Concurrent DAC Trials. Vascular Access Research

Two Concurrent DAC Trials. Dialysis Access Consortium (DAC) Two Concurrent DAC Trials. Vascular Access Research Vascular Access Research Dialysis Access Consortium Trials: A Good Start Laura M. Dember, M.D. Professor of Medicine Renal, Electrolyte and Hypertension Division University of Pennsylvania ASDIN Meeting

More information

Classification of CKD by Diagnosis

Classification of CKD by Diagnosis Classification of CKD by Diagnosis Diabetic Kidney Disease Glomerular diseases (autoimmune diseases, systemic infections, drugs, neoplasia) Vascular diseases (renal artery disease, hypertension, microangiopathy)

More information

Estimating GFR: From Physiology to Public Health. Outline of Presentation. Applications of GFR Estimations

Estimating GFR: From Physiology to Public Health. Outline of Presentation. Applications of GFR Estimations stimating FR: From Physiology to Public Health Tufts: Andy Levey, Lesley (Stevens) Inker, Chris Schmid, Lucy Zhang, Hocine Tighiouart, Aghogho Okparavero, Cassandra Becker, Li Fan Hopkins: Josef Coresh,

More information

Journal of Chinese Medicine. Vol.20, No.1, Vol.20, No.3,

Journal of Chinese Medicine. Vol.20, No.1, Vol.20, No.3, 163 Journal of Chinese Medicine Vol.20, No.1,2 1-96 Vol.20, No.3,4 97-162 ~ - 145 45-135 21 117 79-19 137-135 ~ - 137 65 87-65 - 145-65 - 153-79 - 153-87 47-137 - 65-87 - 47-145 - 145-47 - 19 164 153 HT7

More information

Section Questions Answers

Section Questions Answers Section Questions Answers Guide to CKD Screening and Evaluation -Alec Otteman, MD Delaying Progression - Paul Drawz, MD, MHS, MS 1. Modifiable risk factors for CKD include: a. Diabetes b. Hypertension

More information

This is the author s version of a work that was submitted/accepted for publication in the following source:

This is the author s version of a work that was submitted/accepted for publication in the following source: This is the author s version of a work that was submitted/accepted for publication in the following source: Kelly, Mark D., Gibson, Abby, Bartlett, Harry, Rowling, Diane, & Patten, John (2013) Tenofovir-associated

More information

CASTLE HOWARD EVENT 2018

CASTLE HOWARD EVENT 2018 Castle Howard Triathlon Saturday 21st July 2018 Castle Howard Triathlon Sunday 22nd July 2018 The 'Brideshead Revisited' Sprint Plus - 800m/46km/8km Includes Macmillan Cancer Support Charity Place Race

More information

RESEARCH INTERESTS AND ACTIVITIES. Key Words: health services research, administrative data, laboratory data, kidney disease, chronic disease

RESEARCH INTERESTS AND ACTIVITIES. Key Words: health services research, administrative data, laboratory data, kidney disease, chronic disease Brenda R Hemmelgarn, BScN, MN, PhD, MD, FRCPC Associate Professor, Departments of Medicine and Community Health Sciences AI-HS Population Health CIHR New RESEARCH INTERESTS AND ACTIVITIES Key Words: health

More information

Risk factors of chronic renal failure after atypical Hemolytic Uremic Syndrome under plasmatherapy

Risk factors of chronic renal failure after atypical Hemolytic Uremic Syndrome under plasmatherapy Risk factors of chronic renal failure after atypical Hemolytic Uremic Syndrome under plasmatherapy Professeur Eric Rondeau Urgences néphrologiques et Transplantation rénale Hôpital Tenon, Paris WWA SFH

More information

Primary Care Physicians and Clinicians. XXX on behalf of the Upper Midwest Fistula First Coalition. Chronic Kidney Disease (CKD) Resources

Primary Care Physicians and Clinicians. XXX on behalf of the Upper Midwest Fistula First Coalition. Chronic Kidney Disease (CKD) Resources August 10, 2007 To: From: RE: Primary Care Physicians and Clinicians XXX on behalf of the Upper Midwest Fistula First Coalition Chronic Kidney Disease (CKD) Resources Caring for patients with chronic kidney

More information

17:00 17:45 Meet-the-Professor Immuno-Oncology Fan Yang, Beijing, Christoph Zielinski, Vienna

17:00 17:45 Meet-the-Professor Immuno-Oncology Fan Yang, Beijing, Christoph Zielinski, Vienna 8 th Chinese German Lung Cancer Forum Dresden, Germany, September 8-10, 2016 Precision oncology in lung cancer Thursday, September 8, 2016 17:00 17:45 Meet-the-Professor Immuno-Oncology Fan Yang, Beijing,

More information

Zuni Health Initiative

Zuni Health Initiative ZUNI JEWELRY Zuni Health Initiative Raj Shah-University of New Mexico vshah@salud.unm.edu Do' tse'mak i:k'oshudu, elek'yanna!!! May you feel better, everything will be alright!!! OBJECTIVES Describe the

More information

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009

The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,

More information

Disclosures. Outline. Outline 5/23/17 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

Disclosures. Outline. Outline 5/23/17 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

Research Article Renal Function and Death in Older Women: Which egfr Formula Should We Use?

Research Article Renal Function and Death in Older Women: Which egfr Formula Should We Use? Hindawi International Journal of Nephrology Volume 2017, Article ID 8216878, 10 pages https://doi.org/10.1155/2017/8216878 Research Article Renal Function and Death in Older Women: Which egfr Formula Should

More information

Disclosures. Outline. Outline 7/27/2017 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

Disclosures. Outline. Outline 7/27/2017 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

Effects of Kidney Disease on Cardiovascular Morbidity and Mortality

Effects of Kidney Disease on Cardiovascular Morbidity and Mortality Effects of Kidney Disease on Cardiovascular Morbidity and Mortality Joachim H. Ix, MD, MAS Assistant Professor in Residence Division of Nephrology University of California San Diego, and Veterans Affairs

More information

Primary Care Approach to Management of CKD

Primary Care Approach to Management of CKD Primary Care Approach to Management of CKD This PowerPoint was developed through a collaboration between the National Kidney Foundation and ASCP. Copyright 2018 National Kidney Foundation and ASCP Low

More information

M.Weitz has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve.

M.Weitz has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve. M.Weitz has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve. Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic

More information

Chronic kidney disease and life expectancy

Chronic kidney disease and life expectancy Nephrol Dial Transplant (2012) 27: 3182 3186 doi: 10.1093/ndt/gfs052 Advance Access publication 22 March 2012 Chronic kidney disease and life expectancy Tanvir Chowdhury Turin 1, Marcello Tonelli 2, Braden

More information

Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly?

Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly? Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly? Miklos Z Molnar, MD, PhD, FEBTM, FERA, FASN Associate Professor of Medicine Division of Nephrology, Department of Medicine University

More information

Safety and Efficacy of Eculizumab in Pediatric Patients With ahus, With or Without Baseline Dialysis

Safety and Efficacy of Eculizumab in Pediatric Patients With ahus, With or Without Baseline Dialysis SA-PO546 Safety and Efficacy of Eculizumab in Pediatric Patients With ahus, With or Without Baseline Johan Vande Walle, 1 Larry A. Greenbaum, 2 Camille L. Bedrosian, 3 Masayo Ogawa, 3 John F. Kincaid,

More information

Logjammer 2013 Age Group Results

Logjammer 2013 Age Group Results Female Overall Winners 1 Rachel Olson 22 525 4 19:57.3 6:26/M 2 Crystal Coburn Bossier City 29 617 8 25:33.5 8:15/M Male Overall Winners 1 Reed Keen 16 615 1 18:27.9 5:57/M 2 Luke Keen Shreveport 14 614

More information

Chapter 1: CKD in the General Population

Chapter 1: CKD in the General Population Chapter 1: CKD in the General Population Overall prevalence of CKD (Stages 1-5) in the U.S. adult general population was 14.8% in 2011-2014. CKD Stage 3 is the most prevalent (NHANES: Figure 1.2 and Table

More information

Hemodialysis Fistula Maturation Consortium

Hemodialysis Fistula Maturation Consortium Hemodialysis Fistula Maturation Consortium Rationale for Fistula Maturation Study Dialysis Access Consortium AVF study 60% of new AVFs were unusable for dialysis at 4-5 months post surgery No predictors

More information

Atypical Hemolytic Uremic Syndrome: When the Environment and Mutations Affect Organ Systems. A Case Report with Review of Literature

Atypical Hemolytic Uremic Syndrome: When the Environment and Mutations Affect Organ Systems. A Case Report with Review of Literature Atypical Hemolytic Uremic Syndrome: When the Environment and Mutations Affect Organ Systems. A Case Report with Review of Literature Mouhanna Abu Ghanimeh 1, Omar Abughanimeh 1, Ayman Qasrawi 1, Abdulraheem

More information

Access to ahus Treatment: 2016 ahus Global Poll White Paper

Access to ahus Treatment: 2016 ahus Global Poll White Paper Access to ahus Treatment: 2016 ahus Global Poll White Paper Orphan Drug Access Are Rare Disease Treatments like Eculizumab Equally Available Worldwide? In an era of social media, sharing patient stories

More information

24 h. P > h. R doi /j. issn

24 h. P > h. R doi /j. issn 38 4 2015 4 Vol. 38 No. 4 Apr. 2015 Journal of Beijing University of Traditional Chinese Medicine 271 2 ~ 3 * 1 2 2 2 2 2 1# 1 201203 2 2 ~ 3 55 2 18 37 24 2 0 8 16 24 24 h 2 P > 0. 05 P < 0. 05 P < 0.

More information

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD? CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

Safety and Efficacy of Eculizumab in Pediatric Patients With ahus, With or Without Baseline Dialysis

Safety and Efficacy of Eculizumab in Pediatric Patients With ahus, With or Without Baseline Dialysis SP281 Safety and Efficacy of Eculizumab in Pediatric Patients With ahus, With or Without Baseline Johan Vande Walle, 1 Larry A. Greenbaum, 2 Camille L. Bedrosian, 3 Masayo Ogawa, 3 John F. Kincaid, 3 Chantal

More information

Chronic Renal Failure Followed by Acute Renal Failure

Chronic Renal Failure Followed by Acute Renal Failure Chronic Renal Failure Followed by Acute Renal Failure Dr Emre Karakoç Çukurova Üniversity Department of Medical ICU Terminology Acute Kidney Injury Chronic Kidney Disease Acute Kidney Disease Acute kidney

More information

UWA Research Publication

UWA Research Publication UWA Research Publication Lim, W.H., Lewis, J.R., Wong, G., Dogra, G.K., Zhu, K., Lim, E.M., Dhaliwal, S.S. & Prince, R.L. (). Five-year decline in estimated glomerular filtration rate associated with a

More information

The Impacts of Albuminuria and egfr on Cardiovascular Disease

The Impacts of Albuminuria and egfr on Cardiovascular Disease American Journal of Health Research 2017; 5(4): 99-105 http://www.sciencepublishinggroup.com/j/ajhr doi: 10.11648/j.ajhr.20170504.12 ISSN: 2330-8788 (Print); ISSN: 2330-8796 (Online) The Impacts of Albuminuria

More information

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Shannon H. Norris, BSN, RN June 6, 2018 Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality DISCUSSION: End Stage

More information

Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation

Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation Article Pathogenic s in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation Fadi Fakhouri, Marc Fila, François Provôt, Yahsou Delmas, Christelle Barbet,

More information

MONROE COUNTY SHERIFF'S OFFICE JAIL

MONROE COUNTY SHERIFF'S OFFICE JAIL FEMALE: NUMBER OF PERSONS BY SEX MALE: NUMBER OF PERSONS BY SEX TOTAL NUMBER OF PERSONS IN THE FOR THIS DATE AND TIME: Run Date: 10:15:59 AM Page 1 of 5 Run Date: 10:15:59 AM Page 2 of 5 FEMALE Current

More information

CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH

CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH SCIENTIFIC DIRECTOR KIDNEY HEALTH RESEARCH COLLABORATIVE - UCSF CHIEF - GENERAL INTERNAL MEDICINE, SAN FRANCISCO

More information

Research Article Comparison of CKD-EPI Cystatin C and Creatinine Glomerular Filtration Rate Estimation Equations in Asian Indians

Research Article Comparison of CKD-EPI Cystatin C and Creatinine Glomerular Filtration Rate Estimation Equations in Asian Indians International Nephrology Volume 24, Article ID 746497, 8 pages http://dx.doi.org/.55/24/746497 Research Article Comparison of CKD-EPI Cystatin C and Creatinine Glomerular Filtration Rate Estimation s in

More information

CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW

CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

CURRICULUM VITAE. Keming Yang, MD, MS

CURRICULUM VITAE. Keming Yang, MD, MS CURRICULUM VITAE Keming Yang, MD, MS Department of Epidemiology Richard M. Fairbanks School of Public Health, Indiana University 1050 Wishard Blvd, RG 5129, Indianapolis, IN 46202-2872. Email: kemyang@iu.edu

More information

Quality of Care in Early Stage Chronic Kidney Disease

Quality of Care in Early Stage Chronic Kidney Disease Quality of Care in Early Stage Chronic Kidney Disease 2012 2013 Supplementary Report to the 2015 Alberta Annual Kidney Care Report Kidney Health Strategic Clinical Network December 22, 2015 For more information

More information

Preliminary Agenda. 9:55-10:20 How to overcome TKI resistance? James Chih-Hsin Yang 10:20-10:40 Discussion All 10:40-10:55 Coffee break

Preliminary Agenda. 9:55-10:20 How to overcome TKI resistance? James Chih-Hsin Yang 10:20-10:40 Discussion All 10:40-10:55 Coffee break Preliminary Agenda November 7, 2018 14:00-17:00 Registration and check in Satellite Symposia with Dinner 17:00-18:30 Jiangsu Hengrui Medicine Co., Ltd 17:00-18:30 Satellite Symposia with Dinner 17:00-18:30

More information

Canadian Task Force on Preventive Health Care ~ Public Record of Meeting October 17 & 18, 2016, Hotel Clarendon, Québec City

Canadian Task Force on Preventive Health Care ~ Public Record of Meeting October 17 & 18, 2016, Hotel Clarendon, Québec City Canadian Task Force on Preventive Health Care ~ Public Record of Meeting October 17 & 18, 2016, Hotel Clarendon, Québec City CTFPHC Chairs: Dr. Marcello Tonelli (Chair) Dr. Richard Birtwhistle (Vice-Chair)

More information

Acceptance onto Dialysis Guidelines

Acceptance onto Dialysis Guidelines Guidelines John Kelly (Kogarah, New South Wales) Melissa Stanley (Melbourne, Victoria) David Harris (Westmead, New South Wales) Date written: December 2004 Final submission: June 2005 Predialysis education

More information

Effects of Lowering LDL Cholesterol on Progression of Kidney Disease

Effects of Lowering LDL Cholesterol on Progression of Kidney Disease Effects of Lowering LDL Cholesterol on Progression of Kidney Disease Richard Haynes, David Lewis, Jonathan Emberson, Christina Reith, Lawrence Agodoa, Alan Cass, Jonathan C. Craig, Dick de Zeeuw, Bo Feldt-Rasmussen,

More information

A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records

A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records Clinical Kidney Journal, 2018, vol. 11, no. 2, 254 258 doi: 10.1093/ckj/sfx085 Advance Access Publication Date: 2 August 2017 Original Article ORIGINAL ARTICLE A scheme based on ICD-10 diagnoses and drug

More information

Title: A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy

Title: A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy Author's response to reviews Title: A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy Authors: Nan Zhen Dong (dongzn@301hospital.com.cn) Yong

More information

NIH Public Access Author Manuscript Lancet. Author manuscript; available in PMC 2014 April 21.

NIH Public Access Author Manuscript Lancet. Author manuscript; available in PMC 2014 April 21. NIH Public Access Author Manuscript Published in final edited form as: Lancet. 2010 June 12; 375(9731): 2073 2081. doi:10.1016/s0140-6736(10)60674-5. Association of estimated glomerular filtration rate

More information

Chronic kidney disease-what can you do and when to refer?

Chronic kidney disease-what can you do and when to refer? Chronic kidney disease-what can you do and when to refer? Dr Goh Heong Keong www.passpaces.com/kidney.htm Outline of Lecture Introduction Epidemiology of CKD in Malaysia/ World Complications of CKD What

More information

Dialysis versus Supportive Care

Dialysis versus Supportive Care Dialysis versus Supportive Care with a focus on the initial pathway in the elderly DNT Workshop. Glenelg, February 2017 Background: A better title would be dialysis v non-dialysis! For this discussion:

More information

CURRICULUM VITAE. Employment Experience Distinguished Professor, Department of Pubic Finance, National Cheng-Chi University

CURRICULUM VITAE. Employment Experience Distinguished Professor, Department of Pubic Finance, National Cheng-Chi University May 2013 CURRICULUM VITAE Name Address Telephone and Email Hsien-Ming Lien Department of Public Finance National Cheng-Chi University 64, Zhi-Nan Road, Sec. 2 Wenshan, Taipei 11623, Taiwan 886-2-9378870;

More information

Laboratory Assessment of Diabetic Kidney Disease

Laboratory Assessment of Diabetic Kidney Disease Laboratory Assessment of Diabetic Kidney Disease Andrew S. Narva 1 and Rudolf W. Bilous 2 In Brief Regardless of etiology, chronic kidney disease (CKD) is identified by two laboratory tests: 1) estimated

More information

Long-term outcomes in nondiabetic chronic kidney disease

Long-term outcomes in nondiabetic chronic kidney disease original article http://www.kidney-international.org & 28 International Society of Nephrology Long-term outcomes in nondiabetic chronic kidney disease V Menon 1, X Wang 2, MJ Sarnak 1, LH Hunsicker 3,

More information

IKMG Research Group - 4 th International Meeting PROGRAM

IKMG Research Group - 4 th International Meeting PROGRAM IKMG Research Group - 4 th International Meeting PROGRAM SCIENTIFIC & ORGANIZING COMMITTEE ROYAL Virginie, MD - Chair of the 4th IKMG Meeting VENNER Christopher, MD Co-chair of the 4th IKMG Meeting BRIDOUX

More information

Factors other than glomerular filtration rate affect serum cystatin C levels

Factors other than glomerular filtration rate affect serum cystatin C levels original article http://www.kidney-international.org & 2009 International Society of Nephrology see commentary on page 578 Factors other than glomerular filtration rate affect serum cystatin C levels Lesley

More information

ONCONEPHROLOGY: SATURDAY September 26, Cancer, Chemotherapy and the Kidney. 8:00am 4:00pm. A symposium for nephrologists and cancer specialists

ONCONEPHROLOGY: SATURDAY September 26, Cancer, Chemotherapy and the Kidney. 8:00am 4:00pm. A symposium for nephrologists and cancer specialists ONCONEPHROLOGY: A CME Conference designated for 7 AMA PRA Category I Credits SATURDAY September 26, 2015 8:00am 4:00pm 300 Community Drive Manhasset, NY 11030 north shore-lij health system faculty Thomas

More information

The Association Between Cystatin C and Frailty Status in Older Men

The Association Between Cystatin C and Frailty Status in Older Men The Association Between Cystatin C and Frailty Status in Older Men A THESIS SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY Allyson Hart IN PARTIAL FULFILLMENT OF THE

More information

APA Handbook of Behavior Analysis

APA Handbook of Behavior Analysis APA Handbooks in Psychology APA Handbook of Behavior Analysis VOLUME 1 Methods and Principles Gregory J. Madden, Editor-in-Chief William V. Dube, Timothy D. Hackenberg, Gregory P. Hanley, and Kennon A.

More information

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?

Outline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD? CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

UC Irvine UC Irvine Previously Published Works

UC Irvine UC Irvine Previously Published Works UC Irvine UC Irvine Previously Published Works Title A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death. A1C remains the gold standard outcome predictor

More information

Chronic Kidney Disease - An Overview

Chronic Kidney Disease - An Overview REVIEW ARTICLE KERALA MEDICAL JOURNAL Chronic Kidney Disease - An Overview Rajesh R Nair Department of Nephrology, Amrita Institute of Medical Sciences, Kochi, Kerala* ABSTRACT Published on 28 th December

More information

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives

Objectives. Pre-dialysis CKD: The Problem. Pre-dialysis CKD: The Problem. Objectives The Role of the Primary Physician and the Nephrologist in the Management of Chronic Kidney Disease () By Brian Young, M.D. Assistant Clinical Professor of Medicine David Geffen School of Medicine at UCLA

More information

Removing Barriers To Dermatologic Care Of The Uninsured

Removing Barriers To Dermatologic Care Of The Uninsured Removing Barriers To Dermatologic Care Of The Uninsured Texas Dermatological Society Cloyce L. Stetson, M.D., President; Laura Madole, Executive Director The Free Clinic Fiona Prabhu, M.D., Medical Director

More information

End stage renal disease and Protein Energy wasting

End stage renal disease and Protein Energy wasting End stage renal disease and Protein Energy wasting Dr Goh Heong Keong MBBS,MRCP(UK) www.passpaces.com/kidney.htm Introduction Chronic kidney disease- increasing health burden in many countries. The estimated

More information

Association of Vascular Access Type with Mortality, Hospitalization, and Transfer to In-Center Hemodialysis in Patients Undergoing Home Hemodialysis

Association of Vascular Access Type with Mortality, Hospitalization, and Transfer to In-Center Hemodialysis in Patients Undergoing Home Hemodialysis Article Association of Vascular Access Type with Mortality, Hospitalization, and Transfer to In-Center Hemodialysis in Patients Undergoing Home Hemodialysis Matthew B. Rivara,* Melissa Soohoo, Elani Streja,

More information

Characteristics of Patients Initializing Peritoneal Dialysis Treatment From 2007 to 2014 Analysis From Henan Peritoneal Dialysis Registry data

Characteristics of Patients Initializing Peritoneal Dialysis Treatment From 2007 to 2014 Analysis From Henan Peritoneal Dialysis Registry data DIALYSIS Characteristics of Patients Initializing Peritoneal Dialysis Treatment From 7 to 14 Analysis From Henan Peritoneal Dialysis Registry data Xiaoxue Zhang, 1 Ying Chen, 1,2 Yamei Cai, 1 Xing Tian,

More information

Management of Early Kidney Disease: What to do Before Referring to the Nephrologist

Management of Early Kidney Disease: What to do Before Referring to the Nephrologist Management of Early Kidney Disease: What to do Before Referring to the Nephrologist Andrew S. Narva, MD, NIDDK Saturday, February 18, 2017 8:45 a.m. 9:30 a.m. Although evidence-based guidelines for managing

More information

Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population

Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population 3176 Nephrol Dial Transplant (2011) 26: 3176 3181 doi: 10.1093/ndt/gfr003 Advance Access publication 16 February 2011 Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian

More information

Canadian Task Force on Preventive Health Care ~ Public Record of Meeting June 12 & 13, 2017, Best Western Plus Downtown Suites, Ottawa

Canadian Task Force on Preventive Health Care ~ Public Record of Meeting June 12 & 13, 2017, Best Western Plus Downtown Suites, Ottawa Canadian Task Force on Preventive Health Care ~ Public Record of Meeting June 12 & 13, 2017, Best Western Plus Downtown Suites, Ottawa CTFPHC Chairs: Marcello Tonelli (Chair) Brett Thombs (Chair-Elect)

More information

MDRD vs. CKD-EPI in comparison to

MDRD vs. CKD-EPI in comparison to Jalalonmuhali et al. BMC Nephrology (2017) 18:363 DOI 10.1186/s12882-017-0776-2 RESEARCH ARTICLE MDRD vs. CKD-EPI in comparison to 51 Chromium EDTA: a cross sectional study of Malaysian CKD cohort Maisarah

More information

Preoperative Venous Intimal Hyperplasia, Postoperative Arteriovenous Fistula Stenosis, and Clinical Fistula Outcomes

Preoperative Venous Intimal Hyperplasia, Postoperative Arteriovenous Fistula Stenosis, and Clinical Fistula Outcomes Article Preoperative Venous Intimal Hyperplasia, Postoperative Arteriovenous Fistula Stenosis, and Clinical Fistula Outcomes Michael Allon,* Michelle L. Robbin, Carlton J. Young, Mark H. Deierhoi, Jeremy

More information

Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C

Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C T h e n e w e ngl a nd j o u r na l o f m e dic i n e original article Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C Lesley A. Inker, M.D., Christopher H. Schmid, Ph.D., Hocine

More information

The Seventh Report of the Joint National Commission

The Seventh Report of the Joint National Commission The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow-up of the Modification of Diet in Renal Disease Study Mark J. Sarnak, MD; Tom Greene, PhD; Xuelei Wang,

More information

How is the dialysis patient different?

How is the dialysis patient different? How is the dialysis patient different? Mihály Tapolyai, MD, FASN, FACP Fresenius Medical Care SOTE, Budapest; Hungary Minneapolis VAMC, Minneapolis, MN; USA How is the dialysis patient different? Dialysis

More information

CKDinform: A PCP s Guide to CKD Detection and Delaying Progression

CKDinform: A PCP s Guide to CKD Detection and Delaying Progression CKDinform: A PCP s Guide to CKD Detection and Delaying Progression Learning Objectives Describe suitable screening tools, such as GFR and ACR, for proper utilization in clinical practice related to the

More information

CKD and risk management : NICE guideline

CKD and risk management : NICE guideline CKD and risk management : NICE guideline 2008-2014 Shahed Ahmed Consultant Nephrologist shahed.ahmed@rlbuht.nhs.uk Key points : Changing parameters of CKD and NICE guidance CKD and age related change of

More information

Change in the estimated glomerular filtration rate over time and risk of all-cause mortality

Change in the estimated glomerular filtration rate over time and risk of all-cause mortality clinical investigation http://www.kidney-international.org & 2013 International Society of Nephrology see commentary on page 550 Change in the estimated glomerular filtration rate over time and risk of

More information

Nephrology referral - Does my patient need it? Disclosure

Nephrology referral - Does my patient need it? Disclosure Nephrology referral - Does my patient need it? Sophia Chou, MD MSc March 10, 2018 Faculty: Sophia Chou Disclosure Relationships with commercial interest: None Potential conflict of interest: None 1 Objectives

More information

Descendants of Harold Peter LIBBERTON (1 of 10)

Descendants of Harold Peter LIBBERTON (1 of 10) Descendants of Harold Peter (1 of 10) 1042 Harold Peter 31 Mar 1909, Mount Carroll,, Illinois, Died: 08 Mar 1983,,, Missouri, 1146 Eloys Ernestine PESKA 16 Sep 1912, Fulton,, Illinois, Died: 18 Jun 1996,,,

More information

University of Groningen. Evaluation of renal end points in nephrology trials Weldegiorgis, Misghina Tekeste

University of Groningen. Evaluation of renal end points in nephrology trials Weldegiorgis, Misghina Tekeste University of Groningen Evaluation of renal end points in nephrology trials Weldegiorgis, Misghina Tekeste IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish

More information

The CARI Guidelines Caring for Australians with Renal Impairment. Cardiovascular Risk Factors

The CARI Guidelines Caring for Australians with Renal Impairment. Cardiovascular Risk Factors Cardiovascular Risk Factors ROB WALKER (Dunedin, New Zealand) Lipid-lowering therapy in patients with chronic kidney disease Date written: January 2005 Final submission: August 2005 Author: Rob Walker

More information

CONTEST SCORE REPORT SUMMARY FOR GRADES 6, 7, AND 8 Summary of Results 6th Grade Contests ALML

CONTEST SCORE REPORT SUMMARY FOR GRADES 6, 7, AND 8 Summary of Results 6th Grade Contests ALML 07-0 CONTEST SCORE REPORT SUMMARY FOR GRADES 6, 7, AND Summary of Results 6th Grade Contests ALML Top s in League--6th Grade ( s) * Milam Elem. Tupelo, MS 0 * Metairie Park CDS Metairie, LA 9 Muscle Shoals

More information

STANDARDISED OUTCOMES IN NEPHROLOGY Kidney Transplantation (SONG-Tx)

STANDARDISED OUTCOMES IN NEPHROLOGY Kidney Transplantation (SONG-Tx) STANDARDISED OUTCOMES IN NEPHROLOGY Kidney Transplantation (SONG-Tx) CONSENSUS WORKSHOPS ON ESTABLISHING CORE OUTCOME DOMAINS IN KIDNEY TRANSPLANTATION FRIDAY 11 th NOVEMBER 2016 COMET Meeting, Amsterdam,

More information

Outline Descendant Report for Pierre Perrier-Olivier

Outline Descendant Report for Pierre Perrier-Olivier 1 Pierre Perrier-Olivier + Marie-Josèphte Lemieux... 2 Marie-Josèphte Perrier-Olivier (1750 - ) B: Abt. 1750... + Jean-Louis Dupré (1750 - ) B: January 1750... 3 Alexis Dupré... + Marguerite Cardinal...

More information

Transplant Success in Sensitized Patients Receiving a Standardized Desensitization Therapy: 3 Year Outcomes

Transplant Success in Sensitized Patients Receiving a Standardized Desensitization Therapy: 3 Year Outcomes Transplant Success in Sensitized Patients Receiving a Standardized Desensitization Therapy: 3 Year Outcomes INTRODUCTION In patients awaiting a transplant, having antibodies reactive to HLA antigens present

More information

Soliris (eculizumab) Inhibits TMA and Improves Renal Function in Pediatric and Adult Patients with atypical Hemolytic Uremic Syndrome (ahus)

Soliris (eculizumab) Inhibits TMA and Improves Renal Function in Pediatric and Adult Patients with atypical Hemolytic Uremic Syndrome (ahus) Soliris (eculizumab) Inhibits TMA and Improves Renal Function in Pediatric and Adult Patients with atypical Hemolytic Uremic Syndrome (ahus) New Data from the Largest Prospective Trial of Adult Patients

More information

Outline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?

Outline. Outline 10/14/2014 CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD? CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,

More information

A New Modified CKD-EPI Equation for Chinese Patients with Type 2 Diabetes

A New Modified CKD-EPI Equation for Chinese Patients with Type 2 Diabetes A New Modified CKD-EPI Equation for Chinese Patients with Type 2 Diabetes Xun Liu 1. a, Xiaoliang Gan 2., Jinxia Chen 1 b, Linsheng Lv 3, Ming Li 1, Tanqi Lou 1 * 1 Division of Nephrology, Department of

More information

Care Interventions on the Health Indicators of Patients with Early-Stage Chronic Kidney Disease

Care Interventions on the Health Indicators of Patients with Early-Stage Chronic Kidney Disease Journal of Applied Medical Sciences, vol. 3, no. 1, 2014, 47-60 ISSN: 2241-2328 (print version), 2241-2336 (online) Scienpress Ltd, 2014 Care Interventions on the Health Indicators of Patients with Early-Stage

More information

Research Article Preinterventional Cystatin C: A Highly Prognostic Marker for All-Cause Mortality after Coronarography

Research Article Preinterventional Cystatin C: A Highly Prognostic Marker for All-Cause Mortality after Coronarography Advances in Nephrology, Article ID 510209, 6 pages http://dx.doi.org/10.1155/2014/510209 Research Article Preinterventional Cystatin C: A Highly Prognostic Marker for All-Cause Mortality after Coronarography

More information

Statement and Return Report for Certification

Statement and Return Report for Certification Statement and Return Report for Certification - Judge of the Civil Court - County Kings Vote for Page of 3 Assembly District 4 9,776 Total Ballots,659 AMIRA SOLIMAN (WRITE-IN) ANTHONY MAMMINA (WRITE-IN)

More information

The use of surrogates as key performance indicators

The use of surrogates as key performance indicators REPLY The use of surrogates as key performance indicators Dr José Vinhas Department of Nephrology, Centro Hospitalar de Setúbal. Setúbal, Portugal Received for publication: 24/08/2012 Accepted: 31/08/2012

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Loupy A, Lefaucheur C, Vernerey D, et al. Complement-binding

More information

Timely Referral to Outpatient Nephrology Care Slows Progression and Reduces Treatment Costs of Chronic Kidney Diseases

Timely Referral to Outpatient Nephrology Care Slows Progression and Reduces Treatment Costs of Chronic Kidney Diseases CLINICAL RESEARCH Timely Referral to Outpatient Nephrology Care Slows Progression and Reduces Treatment Costs of Chronic Kidney Diseases Gerhard Lonnemann 1, Johannes Duttlinger 1, David Hohmann 2, Lennart

More information

Pathology of Complement Mediated Renal Disease

Pathology of Complement Mediated Renal Disease Pathology of Complement Mediated Renal Disease Mariam Priya Alexander, MD Associate Professor of Pathology GN Symposium Hong Kong Society of Nephrology July 8 th, 2017 2017 MFMER slide-1 The complement

More information

Lessons learned from AASK (African-American Study of Kidney Disease and Hypertension)

Lessons learned from AASK (African-American Study of Kidney Disease and Hypertension) Lessons learned from AASK (African-American Study of Kidney Disease and Hypertension) Janice P. Lea, MD, MSc, FASN Professor of Medicine Chief Medical Director of Emory Dialysis ASH Clinical Specialist

More information

2015 Poster Presentations

2015 Poster Presentations 1. Herbal CKD: Evaluating the Safety of Natural Health Products in Chronic Kidney Disease and Renal Transplant St. Paul's Hospital- Kidney Care Clinic, Providence Health Care Sharon Leung Josh Batterink,

More information